These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1794262)

  • 21. Is sulphonylurea therapy effective long term? A 3-year study with gliclazide.
    Zurro Hernandez J; Lavielle R
    Curr Med Res Opin; 1986; 10(5):351-8. PubMed ID: 3816294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short- and long-term gliclazide effects on pancreatic islet cell function and hepatic insulin extraction in non-insulin-dependent diabetes mellitus.
    Wajchenberg BL; Santomauro AT; Giannella-Neto D; Borghi VC; Porrelli RN
    Diabetes Res Clin Pract; 1992 Aug; 17(2):89-97. PubMed ID: 1425152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.
    Paton RC; Kernoff PB; Wales JK; McNicol GP
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1018-20. PubMed ID: 6794745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential of gliclazide, a sulphonylurea to influence the oxidative processes within the pathogenesis of diabetic vascular disease.
    Jennings PE
    Adv Exp Med Biol; 1994; 366():313-24. PubMed ID: 7771262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of gliclazide on plasma lipids and pancreatic beta cell function in non-insulin-dependent diabetes mellitus.
    Chen KW; Juang JH; Huang HS; Lin JD; Huang BY; Huang MJ
    Changgeng Yi Xue Za Zhi; 1993 Dec; 16(4):246-50. PubMed ID: 8313208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
    Serradas P; Bailbé D; Portha B
    Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patients.
    Bak JF; Schmitz O; Sørensen NS; Pedersen O
    Diabetes; 1989 Nov; 38(11):1343-50. PubMed ID: 2559864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibitory effect of gliclazide on platelet adhesiveness and aggregation in alloxan diabetic rabbits (author's transl)].
    Kuwashima J; Tsuboi T; Komiya M; Fujitani B; Nakamura K; Maeda J; Kaneko H; Yoshida K; Shimizu M
    Yakugaku Zasshi; 1979 Jan; 99(1):59-64. PubMed ID: 430345
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD.
    Noury J; Nandeuil A
    Diabete Metab; 1991 May; 17(1 Pt 2):209-12. PubMed ID: 1936478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect on platelet adhesiveness in diabetics after long-term treatment with a new oral hypoglycaemic agent, gliclazide.
    Rubinjoni Z; Turk Z; Coce F; Mustovic D; Maitre D; Skrabalo Z
    Curr Med Res Opin; 1978; 5(8):625-31. PubMed ID: 361347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation.
    Khanolkar MP; Morris RH; Thomas AW; Bolusani H; Roberts AW; Geen J; Jackson SK; Evans LM
    Atherosclerosis; 2008 Apr; 197(2):718-24. PubMed ID: 17765245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Personal experience with combined treatment of gliclazide and insulin in patients with non-insulin-dependent diabetes (type 2) and late secondary failure of sulphonylureas].
    Zapecka-Dubno B; Wiśniewska K; Szczepanik Z; Kasperska-Czyzykowa T
    Pol Arch Med Wewn; 1993 Jun; 89(6):499-506. PubMed ID: 8415212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the sulphonylurea drugs gliclazide and glibenclamide on blood glucose control and platelet function.
    Klaff LJ; Vinik AI; Jackson WP; Malan E; Kernoff L; Jacobs P
    S Afr Med J; 1979 Aug; 56(7):247-50. PubMed ID: 121645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics.
    Mikov M; Đanić M; Pavlović N; Stanimirov B; Goločorbin-Kon S; Stankov K; Al-Salami H
    Eur J Drug Metab Pharmacokinet; 2018 Jun; 43(3):269-280. PubMed ID: 29039071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents.
    Furlong NJ; Hulme SA; O'Brien SV; Hardy KJ
    Diabet Med; 2003 Nov; 20(11):935-41. PubMed ID: 14632720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiaggregatory activity of hypoglycaemic sulphonylureas.
    Siluk D; Kaliszan R; Haber P; Petrusewicz J; Brzozowski Z; Sut G
    Diabetologia; 2002 Jul; 45(7):1034-7. PubMed ID: 12136403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventive and therapeutic effects of gliclazide on diabetic retinopathy: comparison with glibenclamide treatment.
    Minami N; Ikeda Y; Abe M
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():707-11. PubMed ID: 6440314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells.
    Lawrence CL; Proks P; Rodrigo GC; Jones P; Hayabuchi Y; Standen NB; Ashcroft FM
    Diabetologia; 2001 Aug; 44(8):1019-25. PubMed ID: 11484080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus.
    Florkowski CM; Richardson MR; Le Guen C; Jennings PE; O'Donnell MJ; Jones AF; Lunec J; Barnett AH
    Diabetes Res; 1988 Oct; 9(2):87-90. PubMed ID: 3149923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.